Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 72
Filter
1.
Infection ; 45(4): 557-562, 2017 Aug.
Article in English | MEDLINE | ID: mdl-27873166

ABSTRACT

Erysipelothrix rhusiopathiae is a facultative anaerobic Gram-positive rod that occurs widely in nature and is best known in veterinary medicine for causing swine erysipelas. In humans, infections are rare and mainly considered as occupationally acquired zoonosis. A case of E. rhusiopathiae bacteremia most likely associated with home freshwater aquarium handling is reported. The route of transmission was probably a cut with the dorsal fin of a dead pet fish. A short review of clinical presentations, therapeutic considerations and pitfalls of E. rhusiopathiae infections in humans is presented.


Subject(s)
Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Erysipelothrix/physiology , Hobbies , Pets , Aged , Animals , Erysipelothrix Infections/microbiology , Fishes , Humans , Male , Switzerland , Treatment Outcome
3.
J Med Assoc Thai ; 98 Suppl 9: S170-6, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26817228

ABSTRACT

Erysipelothrix rhusiopathiae infection in humans may not be as rare as previously thought. In most cases, the disease is acquired from animals through work-related exposure. Human infection has been reported since the early 1900's up to the present. Unsolved issues associated with this organism include inadequate disease control in animals, difficulty in identification and isolation of the bacteria, diagnostic delay due to unawareness of this uncommon disease or unfamiliarity with the increasingly diverse clinical manifestations, and inappropriate antibiotic use due to misdiagnosis, as well as drug resistance. In this review, we attempt to address the unsolved issues related to human Erysipelothrix infection and suggest possible solutions.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Erysipelothrix Infections/epidemiology , Erysipelothrix/isolation & purification , Animals , Delayed Diagnosis , Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Humans
4.
Pediatr Dermatol ; 31(2): 232-5, 2014.
Article in English | MEDLINE | ID: mdl-22957967

ABSTRACT

Erysipeloid, a cutaneous infection with the gram-positive bacillus Erysipelothrix rhusiopathiae, is typically an occupational dermatosis seen in persons working with livestock or involved in commercial fishing (fishmongers). Other more-generalized forms of infection with this organism also exist, including a septic form usually associated with endocarditis. Many infections may be self-limited. They have rarely been reported in children or in immunocompromised patients. This microbe is sensitive to many mainstream antibiotic agents.


Subject(s)
Erysipelothrix Infections/immunology , Foot Dermatoses/immunology , Immunocompromised Host , Adolescent , Anti-Bacterial Agents/therapeutic use , Biopsy , Erysipelothrix/isolation & purification , Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Female , Foot Dermatoses/diagnosis , Foot Dermatoses/drug therapy , Humans , Penicillins/therapeutic use
6.
BMJ Case Rep ; 16(10)2023 Oct 17.
Article in English | MEDLINE | ID: mdl-37848276

ABSTRACT

Erysipelothrix rhusiopathiae is a pleomorphic Gram-positive bacillus, zoonotic pathogen of mammals, birds and fish. Human disease caused by this organism most commonly occurs following occupational or recreational exposure to infected animals and typically presents as a localised cutaneous disease. Invasive infection resulting in bacteraemia, endocarditis or other distant sequelae is infrequently seen. Most commonly, invasive infection is seen in patients with predisposing risk factors including diabetes, immunocompromising conditions, alcohol use disorder or chronic kidney disease. The organism is highly susceptible to penicillin-class drugs which serve as first-line antimicrobial therapy with prolonged courses typically prescribed for invasive disease, given the predilection of this organism to cause endocarditis. In this report, we present an interesting case of a polymicrobial finger abscess with E. rhusiopathiae bacteraemia following laceration with a fish spine in an immunocompetent patient in Southern US state. This bacteraemic episode was successfully treated with a fluoroquinolone course owing to patient's penicillin allergy.


Subject(s)
Bacteremia , Endocarditis , Erysipelothrix Infections , Erysipelothrix , Animals , Humans , Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Cellulitis/drug therapy , Cellulitis/complications , Endocarditis/drug therapy , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/complications , Penicillins/therapeutic use , Seafood/adverse effects , Mammals
7.
J Med Microbiol ; 71(9)2022 Sep.
Article in English | MEDLINE | ID: mdl-36094891

ABSTRACT

Prosthetic knee joint infection caused by Erysipelothrix rhusiopathiae is uncommon and only one case of recurrent infection has previously been described. Here, we describe the case of a 77-year-old male patient who was admitted to the teaching hospital of Rennes (France) with bilateral and nocturnal gonalgia evolving for 1 month. He had bilateral knee prosthesis 10 years ago, and a history of large B-cell lymphoma in remission. A diagnosis of infective endocarditis, with prosthetic knee infection, was made, with positive cultures of synovial fluids and blood; colonies of E. rhusiopathiae were identified by MALDI-TOF MS. Initial treatment involved debridement, implant retention surgery and intravenous amoxicillin (12 g day-1) for 6 weeks with gentamicin 3 mg kg-1 day-1 added for the first 4 days. One year later, a second episode of E. rhusiopathiae infection occurred, suggesting a recurrence or reinfection due to the same bacterial species. The patient was finally cured after a two-stage exchange with a cemented articulated spacer and a 3 month course of amoxicillin (12 g day-1, iv). Different characteristics of E. rhusiopathiae infection were discussed, with a review of all cases of prosthetic joint infections caused by Erysipelothrix species. This case highlights the need for a long-term survey of patients, and a good knowledge of their environment to avoid any risk of reinfection.


Subject(s)
Arthritis, Infectious , Erysipelothrix Infections , Erysipelothrix , Aged , Amoxicillin , Animals , Arthritis, Infectious/microbiology , Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Erysipelothrix Infections/microbiology , Humans , Male , Reinfection
8.
J Infect Chemother ; 17(5): 703-5, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21409531

ABSTRACT

Erysipelothrix rhusiopathiae is a gram-positive bacillus which is found worldwide. Although bloodstream infections caused by E. rhusiopathiae are not common, there is a strong association between bacteremia and the development of infective endocarditis. The risk of human infection with Erysipelothrix is closely related to the opportunity for exposure to the organisms. We report a case of community-acquired meningitis as an initial manifestation of E. rhusiopathiae endocarditis in a 56-year-old woman, who had no history of exposure to animals.


Subject(s)
Endocarditis, Bacterial/diagnosis , Erysipelothrix Infections/diagnosis , Erysipelothrix/isolation & purification , Meningitis, Bacterial/diagnosis , Acute Disease , Aged , Anti-Bacterial Agents/therapeutic use , Ceftriaxone/therapeutic use , Endocarditis, Bacterial/drug therapy , Endocarditis, Bacterial/microbiology , Erysipelothrix Infections/drug therapy , Erysipelothrix Infections/microbiology , Female , Humans , Male , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/microbiology , Middle Aged
9.
JBJS Case Connect ; 11(4)2021 12 15.
Article in English | MEDLINE | ID: mdl-34910716

ABSTRACT

CASE: We report the case of an immunosuppressed 65-year-old man with prosthetic joint infection (PJI) 23 years postoperatively because of Erysipelothrix rhusiopathiae, through hematogenous seeding of cutaneous erysipeloid. Immunotherapy was discontinued, washout was performed, and antimicrobial therapy was guided by laboratory sensitivities. The patient was discharged on suppressive oral ciprofloxacin monotherapy. First-stage revision was performed at 5 months after presentation-subsequent aspiration at 1 year postoperatively demonstrated no organisms and no leucocytes. At 18-month follow-up, the patient continues to do well and has elected not to proceed with second-stage surgery. CONCLUSION: E. rhusiopathiae is a rarely seen pathogen in PJI-it should be considered with immunosuppression and relevant exposure risks. The patient achieved good clinical outcome and has experienced no sequelae to date.


Subject(s)
Arthritis, Infectious , Erysipelothrix Infections , Erysipelothrix , Aged , Animals , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/drug therapy , Ciprofloxacin , Erysipelothrix Infections/drug therapy , Humans , Male
10.
Can J Cardiol ; 37(3): 523.e1-523.e3, 2021 03.
Article in English | MEDLINE | ID: mdl-32920167

ABSTRACT

Erysipelothrix rhusiopathiae, is an important animal pathogen, but rarely reported in humans. To date, only fa ew cases of infective E rhusiopathiae endocarditis of the aortic valve have been described. We introduce the first reported case of severe damage of the native unicuspid aortic valve complicated with acquired ventricular septal defect caused by E rhusiopathiae endocarditis. This case may provide a better understanding of the disease process and transmission and underscores the need to include this pathogen in the differential diagnosis of infective endocarditis.


Subject(s)
Endocarditis, Bacterial/etiology , Erysipelothrix Infections/etiology , Erysipelothrix/isolation & purification , Heart Septal Defects, Ventricular/complications , Heart Valve Diseases/complications , Anti-Bacterial Agents/therapeutic use , Echocardiography , Endocarditis, Bacterial/diagnosis , Erysipelothrix Infections/drug therapy , Erysipelothrix Infections/microbiology , Heart Septal Defects, Ventricular/diagnosis , Humans , Male , Middle Aged
11.
J Korean Med Sci ; 25(8): 1234-6, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20676340

ABSTRACT

Erysipelothrix rhusiopathiae is known as a pathogen of occupational diseases or a zoonosis. We report a case of E. rhusiopathiae peritonitis in a 50-yr-old male undergoing continuous ambulatory peritoneal dialysis (CAPD). He was suffered from mild abdominal pain with a distinctive erysipeloid skin lesion. E. rhusiopathiae was considered to be introduced through a lacerated wound on his hand when he was exposed to contaminated materials. He was treated successfully with a first generation cephalosporin. To our knowledge, CAPD peritonitis due to E. rhusiopathiae is very rare, and this is a report of the first case in Asia.


Subject(s)
Erysipelothrix Infections/diagnosis , Erysipelothrix , Peritoneal Dialysis, Continuous Ambulatory , Peritonitis/diagnosis , Anti-Bacterial Agents/therapeutic use , Cefazolin/therapeutic use , Erysipelothrix/isolation & purification , Erysipelothrix Infections/drug therapy , Humans , Injections, Intraperitoneal , Male , Middle Aged , Peritonitis/drug therapy
12.
J Vet Med Sci ; 72(5): 643-5, 2010 May.
Article in English | MEDLINE | ID: mdl-20068270

ABSTRACT

The determination of antimicrobial minimum inhibitory concentration (MIC) in Erysipelothrix rhusiopathiae by using the agar dilution method has not been covered by the Clinical and Laboratory Institute (CLSI). Only the broth microdilution method has been outlined. This report describes a modification of the agar dilution procedure for E. rhusiopathiae using Trypto-soy agar supplemented with 0.1% Tween 80 and incubation in ambient air at 37 degrees C for 24 hr. The MICs of the assay were in agreement with those of the broth microdilution method recommended by the CLSI. Antimicrobial susceptibility test was performed using this method for 149 E. rhusiopathiae isolates from 2 meat processing plants in Kagoshima Prefecture during the period of April 2004 to March 2005. The number of strains resistant to oxytetracycline, erythromycin, lincomycin, ofloxacin and enrofloxacin were 56 (37.6%), 4 (2.7%), 18 (12.1%), 21 (14.1%) and 19 (12.8%), respectively. All strains were susceptible to ampicillin.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Erysipelothrix Infections/drug therapy , Erysipelothrix/drug effects , Swine Diseases/microbiology , Swine/microbiology , Animals , Anti-Bacterial Agents/pharmacology , Erysipelothrix/classification , Erysipelothrix/isolation & purification , Japan , Microbial Sensitivity Tests , Species Specificity , Swine Diseases/drug therapy
13.
J Arthroplasty ; 25(3): 497.e21-3, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19195828

ABSTRACT

Invasive infection with animal-associated bacteria, Erysipelotrix rhusiopathiae, is unusual and has, to our knowledge, never been described as the cause of infected total hip arthroplasty. We describe how an infected total hip arthroplasty caused by these bacteria is eradicated using standard surgical and antibiotic treatment. Before 2-stage revision surgery, the patient had persistent groin pain, elevated C-reactive protein, radiographic periprosthetic osteolysis, excessive intra-articular fluid, and periprosthetic activity accumulation on the white cell scan. The patient was treated with benzylpenicillin after confirmed sensitivity of E rhusiopathiae diagnosed by culture of five tissue samples and polymerase chain reaction of the prosthetic sonicate sample. Sixteen weeks after the last stage of revision surgery, there were no signs of reoccurring infection.


Subject(s)
Arthroplasty, Replacement, Hip , Erysipelothrix Infections/complications , Erysipelothrix , Hip Prosthesis/microbiology , Prosthesis-Related Infections/microbiology , Aged , Animals , Anti-Bacterial Agents/therapeutic use , Erysipelothrix Infections/drug therapy , Female , Humans , Osteoarthritis, Hip/surgery , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/surgery , Reoperation/methods , Secondary Prevention , Treatment Outcome
14.
Ann Dermatol Venereol ; 137(2): 124-7, 2010 Feb.
Article in French | MEDLINE | ID: mdl-20171435

ABSTRACT

BACKGROUND: Baker-Rosenbach's erysipeloid is a skin infection caused by Erysipelothrix rhusiopathiae. It occurs essentially in humans exposed to animals colonized with this germ such as swine. The typical skin lesion, an erythematous macule generally localized to inoculation site, frequently in the extremities, quickly resolves spontaneously. The lips are an atypical site of this infection. We describe a case of chronic granulomatosis cheilitis in a farmer caused by E. rhusiopathiae. CASE REPORT: A 40-year-old farmer, a wild-boar hunter and chronic smoker with no history of tuberculosis, injury or insect bites, presented at our dermatology unit with ulcerative macrocheilitis of the lower lip ongoing for 1 year. Its surface was purulent. A biopsy specimen showed non-caseating epithelioid granulomas. Laboratory and radiological screening for tuberculosis, sarcoidosis and Crohn's disease, and parasitological examination for Leishmaniasis proved negative. Bacteriological examination identified E. rhusiopathiae and labial Baker-Rosenbach's erysipeloid was diagnosed. The lesion healed after 15 days of treatment with parenteral penicillin G (12m IU/d), totally disappearing after 3 months. DISCUSSION: Swine erysipelas usually occurs in man as Baker-Rosenbach's erysipeloid. This localized form of infection with E. rhusiopathiae is the most frequent and the lesion typically observed is a violaceous plaque, less inflammatory with induration; spontaneous regression occurs after a mean 3 months. To our knowledge, this case is the first report of ulceration associated with macrocheilitis. Histologically, the granuloma directed our investigation towards the principal aetiologies of granulomatosis cheilitis, such as tuberculosis considering the epidemiological context, sarcoidosis or Crohn's disease. The diagnosis of erysipeloid was supported by epidemiological evidence (occupational exposure), isolation of the germ at the lesion and its regression on treatment with penicillin G. CONCLUSION: Diagnosis of E. rhusiopathiae infection was confirmed by bacteriology. However, the hypothesis concerning the pathogenesis of its chronic course in our patient remains a subject of discussion.


Subject(s)
Cheilitis/microbiology , Erysipelothrix Infections/diagnosis , Adult , Agriculture , Animals , Anti-Bacterial Agents/therapeutic use , Cheilitis/drug therapy , Erysipelothrix Infections/drug therapy , Humans , Male , Penicillin G/therapeutic use
15.
Schweiz Arch Tierheilkd ; 162(12): 771-780, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33263544

ABSTRACT

INTRODUCTION: Polyarthritis caused by Erysipelothrix rhusiopathiae is a well-known disease in pigs, and ovine erysipelas infection also commonly affects two-to-six month-old lambs. This report describes case histories of three sheep flocks where lambs exhibited swollen joints and lameness. Special emphasis was given to clinical and diagnostic imaging findings, synovia sampling and the treatment regime. Lambs with only mild lameness, liquid serofibrinous joint effusion and lambs showing no bone involvement, as revealed by ultrasonography or radiography, were treated with systemically administered antibiotics selected from results of antimicrobial susceptibility testing of E. rhusiopathiae isolated from synovial samples, and non-steroidal anti-inflammatory drugs. Lambs with severe lameness and severely swollen joints were euthanized, and routine necropsy was undertaken with a focus on the joints. Further, a herd-specific autogenous vaccine was produced by a specialized laboratory. In conclusion, E. rhusiopathiae infection should be considered as a differential diagnosis in herds associated with lameness and polyarthritis in lambs aged between two up to 17 months.


INTRODUCTION: La polyarthrite causée par Erysipelothrix rhusiopathiae est une maladie bien connue chez le porc. Chez les ovins, l'infection touche le plus souvent les agneaux âgés de deux à six mois. Ce rapport de cas décrit trois troupeaux de moutons où des agneaux présentaient des articulations enflées et une boiterie. Un accent particulier a été mis sur la clinique, les résultats de l'imagerie diagnostique, les prélèvements de synovie et le mode de traitement. Les agneaux présentant uniquement une légère boiterie, des épanchements articulaires séro-fibrineux et ceux ne présentant pas d'atteinte osseuse, révélée par échographie ou radiographie, ont été traités avec des antibiotiques administrés par voie systémique, sélectionnés à partir des résultats de la sensibilité d'E. Rhusiopathiae isolé sur les échantillons synoviaux, ainsi qu'avec des anti-inflammatoires non stéroïdiens. Les agneaux présentant une boiterie sévère et des articulations gravement enflées ont été euthanasiés et une autopsie de routine a été réalisée avec un accent particulier mis sur les articulations. De plus, un vaccin autogène spécifique au troupeau a été produit par un laboratoire. En conclusion, l'infection à E. rhusiopathiae doit être considérée comme un diagnostic différentiel dans les troupeaux où l'on constate des boiteries et des polyarthrites chez les agneaux âgés de 2 à 17 mois.


Subject(s)
Arthritis/veterinary , Erysipelothrix Infections/complications , Sheep Diseases/etiology , Animals , Arthritis/diagnosis , Arthritis/drug therapy , Arthritis/etiology , Austria , Bacterial Vaccines/standards , Diagnosis, Differential , Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Erysipelothrix Infections/etiology , Sheep , Sheep Diseases/diagnosis , Sheep Diseases/drug therapy , Sheep Diseases/prevention & control
16.
J Med Microbiol ; 56(Pt 10): 1405-1406, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17893181

ABSTRACT

A 47-year-old man presented with headache, nausea, vomiting and fever. Laboratory findings including analysis of cerebrospinal fluid suggested bacterial meningitis. Erysipelothrix rhusiopathiae was identified in cultures of cerebrospinal fluid. The patient recovered without any neurological sequelae after antimicrobial treatment. It is interesting that intracranial infection by E. rhusiopathiae reappeared after scores of years and that it presented with absence of an underlying cause or bacteraemia.


Subject(s)
Erysipelothrix Infections/microbiology , Erysipelothrix/isolation & purification , Meningitis/microbiology , Anti-Bacterial Agents/therapeutic use , Cerebrospinal Fluid/microbiology , Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Humans , Male , Meningitis/diagnosis , Meningitis/drug therapy , Middle Aged
17.
Rev Argent Microbiol ; 37(2): 78-80, 2005.
Article in Spanish | MEDLINE | ID: mdl-16178460

ABSTRACT

A fatal case of Erysipelothrix rhusiopathiae mitral valve endocarditis is described in a 45 years old male, with a history of chronic alcohol abuse and without animals contact. He presented intermittent fever, polyarthralgia, weight loss, and low back pain. In blood cultures (2 bottles), gram-positive pleomorphic rods grew after 48 hours of incubation. The subculture on blood agar media showed a small, alpha-hemolytic colony, catalase and oxidase negative, PYR and LAP positive and the production of H2S in triple sugar iron agar, was demonstrated. The isolate was initially identified as E. rhusiopathiae, and confirmed by API Coryne (BioMérieux). On the basis of these findings and a transthoracic echocardiogram, an endocarditis was confirmed. Intravenous ampicillin and gentamicin treatment was initiated. The patient became afever, nevertheless he died on day 19 after admission as a consequence of acute pulmonary edema. Susceptibility testing by E-test showed that the microorganism was resistant to vancomycin and gentamicin, and susceptible to penicillin and cefotaxime. We emphasize the importance to consider the isolates of gram-positive pleomorphic rods, catalase and oxidase negative, and the addition of H2S production test in TSI medium. Vancomycin-resistance helps in the identification, and to establish the correct antimicrobial therapy. Although E. rhusiopathiae is usually reported as an occupational pathogen, the contact with pigs and other farm animals may be underestimated.


Subject(s)
Endocarditis, Bacterial/microbiology , Erysipelothrix Infections/microbiology , Erysipelothrix/isolation & purification , Mitral Valve/microbiology , Alcoholism/complications , Ampicillin/therapeutic use , Deafness/complications , Diabetes Mellitus, Type 2/complications , Drug Resistance, Multiple, Bacterial , Drug Therapy, Combination , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/diagnostic imaging , Endocarditis, Bacterial/drug therapy , Erysipelothrix/drug effects , Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Fatal Outcome , Gentamicins/therapeutic use , Humans , Male , Middle Aged , Mitral Valve/diagnostic imaging , Pulmonary Edema/etiology , Ultrasonography
18.
Pathology ; 30(4): 391-4, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9839315

ABSTRACT

Erysipelothrix rhusiopathiae is an important animal pathogen with a worldwide distribution, yet this zoonotic infection is rarely reported in humans. Three cases of E. rhusiopathiae infection, which illustrate the varied clinical presentations of this pathogen in humans, are presented together with the pathological findings and treatment regimens.


Subject(s)
Bacteremia/microbiology , Erysipelothrix Infections/microbiology , Erysipelothrix/pathogenicity , Skin Diseases, Bacterial/microbiology , Zoonoses , Adult , Aged , Aged, 80 and over , Amoxicillin/therapeutic use , Animals , Bacteremia/drug therapy , Bacteremia/pathology , Erysipelothrix/isolation & purification , Erysipelothrix Infections/drug therapy , Erysipelothrix Infections/pathology , Humans , Male , Middle Aged , Penicillins/therapeutic use , Skin/microbiology , Skin/pathology , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/pathology , Treatment Outcome
19.
J Infect ; 30(2): 161-3, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7636284
20.
J Formos Med Assoc ; 99(5): 431-4, 2000 May.
Article in English | MEDLINE | ID: mdl-10870336

ABSTRACT

Bacteremia due to Erysipelothrix rhusiopathiae is rare; the most common presentation reported in the literature is endocarditis. We report a 32-year-old man with oropharyngeal cancer who developed aspiration pneumonia and E. rhusiopathiae bacteremia, and presented with fever, chills, dyspnea, and productive cough with purulent sputum. Despite treatment with amoxicillin/clavulanate and nutritional support for 9 days, he died of respiratory failure. He had no clinical evidence of endocarditis. He had no history of animal or occupational exposure, and might have been colonized with E. rhusiopathiae in the oral cavity, followed by aspiration pneumonia and bacteremia. A fatal outcome in a patient with bacteremia due to E. rhusiopathiae without endocarditis is rare.


Subject(s)
Bacteremia/etiology , Erysipelothrix Infections/etiology , Oropharyngeal Neoplasms/complications , Adult , Bacteremia/drug therapy , Erysipelothrix/drug effects , Erysipelothrix Infections/drug therapy , Fatal Outcome , Humans , Male , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL